EMILY PETTIS: Open Payments
NPI 1811390396 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,123 in 60 payments from 12 companies in 2025. Trend: 2023 $1,522 · 2024 $1,192 · 2025 $1,123
Food & beverage: $1,123
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $302 |
| ABBVIE INC. | 25 | $283 |
| UCB, Inc. | 3 | $152 |
| AstraZeneca Pharmaceuticals LP | 2 | $145 |
| Radius Health, Inc. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Aurinia Pharma U.S., Inc. | 1 | $19 |
Products named: EVENITY, RINVOQ, Bimzelx, SAPHNELO, SKYRIZI, Tymlos, Kerendia, KRYSTEXXA.
Industry payments across AL — which companies pay providers there.
